On September 16, 2026, Profusa, Inc. completed an additional closing under its Securities Purchase Agreement with Ascent Partners Fund LLC by issuing a Senior Secured Convertible Promissory Note with a principal amount of $384,615.38 for a purchase price of $350,000. The note bears 7% annual interest payable monthly and matures on September 16, 2027, or upon an Option Closing Date. It is convertible into common stock at $4.28 per share, subject to a floor price of $1.07, and includes mandatory prepayment obligations tied to future offerings. Profusa operates in the biotechnology sector, developing photobiomodulation therapies.
